ADP-Ribosylation Factor 3 Mediates Cytidine-Phosphate-Guanosine Oligodeoxynucleotide-Induced Responses by Regulating Toll-Like Receptor 9 Trafficking

Journal of Innate Immunity

Volumn 7, Issue 6, 2015, Pages 623-636

  Wu, Jing Yiing ^a   Kuo, Cheng Chin ^a,b  

^a NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

^b CHINA MEDICAL UNIVERSITY   (Taiwan)

Author keywords

ADP ribosylation factor 3; CpG oligodeoxynucleotidemediated responses; Toll like receptor 9 trafficking

Indexed keywords

ADENOSINE DIPHOSPHATE RIBOSYLATION FACTOR 3; CPG OLIGODEOXYNUCLEOTIDE; CYTIDINE PHOSPHATE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; MYELOID DIFFERENTIATION FACTOR 88; SMALL INTERFERING RNA; TOLL LIKE RECEPTOR 9; TUMOR NECROSIS FACTOR ALPHA; ADENOSINE DIPHOSPHATE RIBOSYLATION FACTOR; ARF3 PROTEIN, HUMAN; ARF3 PROTEIN, MOUSE; CARRIER PROTEIN; CPG-OLIGONUCLEOTIDE; MYD88 PROTEIN, HUMAN; MYD88 PROTEIN, MOUSE; OLIGODEOXYRIBONUCLEOTIDE; TLR9 PROTEIN, HUMAN; TLR9 PROTEIN, MOUSE; UNC93B1 PROTEIN, HUMAN; UNC93B1 PROTEIN, MOUSE;

ANIMAL CELL; ARTICLE; CONFOCAL MICROSCOPY; CYTOKINE PRODUCTION; ENZYME ACTIVATION; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME PHOSPHORYLATION; FIBROBLAST; HUMAN; HUMAN CELL; INNATE IMMUNITY; INTRACELLULAR MEMBRANE; LUCIFERASE ASSAY; MOUSE; NONHUMAN; PLASMACYTOID DENDRITIC CELL; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; WESTERN BLOTTING; ANIMAL; CELL LINE; DRUG EFFECTS; IMMUNOLOGY; PROTEIN TRANSPORT;

ADP-RIBOSYLATION FACTORS; ANIMALS; CELL LINE; HUMANS; MEMBRANE TRANSPORT PROTEINS; MICE; MYELOID DIFFERENTIATION FACTOR 88; OLIGODEOXYRIBONUCLEOTIDES; PROTEIN TRANSPORT; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTOR 9;

EID: 84945485864     PISSN: 1662811X     EISSN: 16628128     Source Type: Journal    
DOI: 10.1159/000430785     Document Type: Article

References (36)

1. Marshak-Rothstein A: Toll-like receptors in systemic autoimmune disease. Nat Rev Immunol 2006; 6: 823-835.
2. Christensen SR, Shlomchik MJ: Regulation of lupus-related autoantibody production and clinical disease by Toll-like receptors. Semin Immunol 2007; 19: 11-23.
3. Latz E, Schoenemeyer A, Visintin A, Fitzgerald KA, Monks BG, Knetter CF, Lien E, Nilsen NJ, Espevik T, Golenbock DT: TLR9 signals after translocating from the ER to CpG DNA in the lysosome. Nat Immunol 2004; 5: 190-198.
4. Leifer CA, Kennedy MN, Mazzoni A, Lee C, Kruhlak MJ, Segal DM: TLR9 is localized in the endoplasmic reticulum prior to stimulation. J Immunol 2004; 173: 1179-1183.
5. Chockalingam A, Brooks JC, Cameron JL, Blum LK, Leifer CA: TLR9 trafficks through the Golgi complex to localize to endolysosomes and respond to CpG DNA. Immunol Cell Biol 2009; 87: 209-217.
6. Tabeta K, Hoebe K, Janssen EM, Du X, Georgel P, Crozat K, Mudd S, Mann N, Sovath S, Goode J, Shamel L, Herskovits AA, Portnoy DA, Cooke M, Tarantino LM, Wiltshire T, Steinberg BE, Grinstein S, Beutler B: The Unc93B1 mutation 3d disrupts exogenous antigen presentation and signaling via Toll-like receptors 3, 7 and 9. Nat Immunol 2006; 7: 156-164.
7. Brinkmann MM, Spooner E, Hoebe K, Beutler B, Ploegh HL, Kim YM: The interaction between the ER membrane protein UNC93B and TLR3, 7, and 9 is crucial for TLR signaling. J Cell Biol 2007; 177: 265-275.
8. Kim YM, Brinkmann MM, Paquet ME, Ploegh HL: Unc93B1 delivers nucleotidesensing Toll-like receptors to endolysosomes. Nature 2008; 452: 234-238.
9. Lee BL, Moon JE, Shu JH, Yuan L, Newman ZR, Schekman R, Barton GM: Unc93B1 mediates differential trafficking of endosomal TLRs. Elife 2013; 2:e00291.
10. D'Souza-Schorey C, Chavrier P: ARF proteins: roles in membrane traffic and beyond. Nat Rev Mol Cell Biol 2006; 7: 347-358.
11. Dascher C, Balch WE: Dominant inhibitory mutants of ARF1 block endoplasmic reticulum to Golgi transport and trigger disassembly of the Golgi apparatus. J Biol Chem 1994; 269: 1437-1448.
12. Kuo CC, Kuo CW, Liang CM, Liang SM: A transcriptomic and proteomic analysis of the effect of CpG-ODN on human THP-1 monocytic leukemia cells. Proteomics 2005; 5: 894-906.
13. Wu JY, Kuo CC: Pivotal role of ADP-ribosylation factor 6 in Toll-like receptor 9-mediated immune signaling. J Biol Chem 2012; 287: 4323-4334.
14. Kuo CC, Liang SM, Liang CM: CpG-B oligodeoxynucleotide promotes cell survival via up-regulation of Hsp70 to increase Bcl-xL and to decrease apoptosis-inducing factor translocation. J Biol Chem 2006; 281: 38200-38207.
15. Kuo CC, Liang CM, Lai CY, Liang SM: Involvement of heat shock protein (Hsp)90 beta but not Hsp90 alpha in antiapoptotic effect of CpG-B oligodeoxynucleotide. J Immunol 2007; 178: 6100-6108.
16. Lee GL, Chang YW, Wu JY, Wu ML, Wu KK, Yet SF, Kuo CC: TLR 2 induces vascular smooth muscle cell migration through cAMP response element-binding protein-mediated interleukin-6 production. Arterioscler Thromb Vasc Biol 2012; 32: 2751-2760.
17. Inoue H, Randazzo PA: Arf GAPs and their interacting proteins. Traffic 2007; 8: 1465-1475.
18. Randazzo PA, Inoue H, Bharti S: Arf GAPs as regulators of the actin cytoskeleton. Biol Cell 2007; 99: 583-600.
19. Burns K, Martinon F, Esslinger C, Pahl H, Schneider P, Bodmer JL, Di Marco F, French L, Tschopp J: MyD88, an adapter protein involved in interleukin-1 signaling. J Biol Chem 1998; 273: 12203-12209.
20. Kuo CC, Lin WT, Liang CM, Liang SM: Class I and III phosphatidylinositol 3 ?-kinase play distinct roles in TLR signaling pathway. J Immunol 2006; 176: 5943-5949.
21. Wu JY, Kuo CC: TLR9-mediated ARF6 activation is involved in advancing CpG ODN cellular uptake. Commun Integr Biol 2012; 5: 316-318.
22. Ewald SE, Lee BL, Lau L, Wickliffe KE, Shi GP, Chapman HA, Barton GM: The ectodomain of Toll-like receptor 9 is cleaved to generate a functional receptor. Nature 2008; 456: 658-662.
23. Park B, Brinkmann MM, Spooner E, Lee CC, Kim YM, Ploegh HL: Proteolytic cleavage in an endolysosomal compartment is required for activation of Toll-like receptor 9. Nat Immunol 2008; 9: 1407-1414.
24. Peyroche A, Antonny B, Robineau S, Acker J, Cherfils J, Jackson CL: Brefeldin A acts to stabilize an abortive ARF-GDP-Sec7 domain protein complex: involvement of specific residues of the Sec7 domain. Mol Cell 1999; 3: 275-285.
25. Presley JF, Ward TH, Pfeifer AC, Siggia ED, Phair RD, Lippincott-Schwartz J: Dissection of COPI and Arf1 dynamics in vivo and role in Golgi membrane transport. Nature 2002; 417: 187-193.
26. Sciaky N, Presley J, Smith C, Zaal KJ, Cole N, Moreira JE, Terasaki M, Siggia E, Lippincott-Schwartz J: Golgi tubule traffic and the effects of brefeldin A visualized in living cells. J Cell Biol 1997; 139: 1137-1155.
27. Kondo Y, Hanai A, Nakai W, Katoh Y, Nakayama K, Shin HW: ARF1 and ARF3 are required for the integrity of recycling endosomes and the recycling pathway. Cell Struct Funct 2012; 37: 141-154.
28. Cox R, Mason-Gamer RJ, Jackson CL, Segev N: Phylogenetic analysis of Sec7-domaincontaining Arf nucleotide exchangers. Mol Biol Cell 2004; 15: 1487-1505.
29. Mouratou B, Biou V, Joubert A, Cohen J, Shields DJ, Geldner N, Jurgens G, Melancon P, Cherfils J: The domain architecture of large guanine nucleotide exchange factors for the small GTP-binding protein Arf. BMC Genomics 2005; 6: 20.
30. Manolea F, Chun J, Chen DW, Clarke I, Summerfeldt N, Dacks JB, Melancon P: Arf3 is activated uniquely at the trans-Golgi network by brefeldin A-inhibited guanine nucleotide exchange factors. Mol Biol Cell 2010; 21: 1836-1849.
31. Krieg AM: CpG motifs in bacterial DNA and their immune effects. Annu Rev Immunol 2002; 20: 709-760.
32. Honda K, Ohba Y, Yanai H, Negishi H, Mizutani T, Takaoka A, Taya C, Taniguchi T: Spatiotemporal regulation of MyD88-IRF-7 signalling for robust type-I interferon induction. Nature 2005; 434: 1035-1040.
33. Verthelyi D, Zeuner RA: Differential signaling by CpG DNA in DCs and B cells: not just TLR9. Trends Immunol 2003; 24: 519-522.
34. Lenert P, Rasmussen W, Ashman RF, Ballas ZK: Structural characterization of the inhibitory DNA motif for the type A (D)-CpG-induced cytokine secretion and NK-cell lytic activity in mouse spleen cells. DNA Cell Biol 2003; 22: 621-631.
35. Hartmann G, Battiany J, Poeck H, Wagner M, Kerkmann M, Lubenow N, Rothenfusser S, Endres S: Rational design of new CpG oligonucleotides that combine B cell activation with high IFN-alpha induction in plasmacytoid dendritic cells. Eur J Immunol 2003; 33: 1633-1641.
36. Zanetti G, Pahuja KB, Studer S, Shim S, Schekman R: COPII and the regulation of protein sorting in mammals. Nat Cell Biol 2012; 14: 20-28.